The Asangani Lab at the University of Pennsylvania; we study Transcriptional Addiction in Cancer.
Philadelphia
- Tweets 35
- Following 172
- Followers 211
- Likes 71
Pinned Tweet
Asangani Lab is funded again by DoD. This time DoD Idea Expansion award to study the PP2A-AR axis in refractory prostate cancer. 😀
7
3
47
Irfan Asangani retweeted
The University of Pennsylvania @PennMedicine Department of Cancer Biology @Penn_CBIO seeks MD and/or PhD candidates for multiple tenure track positions at the Assistant Professor level. Applicants with expertise in any specific area of CBIO are encouraged. apply.interfolio.com/96881
1
32
41
Irfan Asangani retweeted
The @AsanganiLab is looking for a postdoc in Cancer Epigenomics and Transcriptional Addiction - learn more about the position at the link below and come join a great team! bit.ly/2Sxm2ip
5
5
Irfan Asangani retweeted
If you are refusing to get vaccinated against COVID-19, maybe it's because you are getting your medical advice from news pundits, fearmongers, conspiracy theorists, and other deeply misinformed people, rather than from Medical Professionals.
2,218
10,272
50,954
Irfan Asangani retweeted
Many thanks to @AsanganiLab @CD_AACR View: p300/CBP inhibition, CCS1477. A novel therapeutic approach for AR-addicted advanced prostate cancer. cancerdiscovery.aacrjournals…
6
5
Our COVID-19 paper is out in iScience (Cell Press). Extremely proud of first authors @deng_qu @Reyazrasool and Ram Natesan for their contribution to this critical pandemic-related work. #COVID19 #ACE2 #TMPRSS2 @PennMedicine @PennEpiInst @PCFnews
cell.com/iscience/fulltext/S…
5
24
Excited to share our new study on Ewing Sarcoma (EwS). Here we discover stereociliary protein LOXHD1 as a novel oncogene and a potential tumor antigen in EwS.
biorxiv.org/content/10.1101/…
#sarcoma #immunotherapy #enhancer @GrunewaldLab @deng_qu @biorxivpreprint
8
15
Irfan Asangani retweeted
Just learned we received funding from @theNCI #BeauBidenCancerMoonshot to study lineage plasticity in prostate cancer! Looking for talented post-docs to drive this project @UMRogelCancer! Please apply and re-tweet! @PCF_Science @UrologySBUR @AmerUrological @UmichCancBio @UMich
12
19
82
Irfan Asangani retweeted
Very excited to share our results about novel subtypes of metastatic castration-resistant prostate cancer ! Led by the awesome @FanyingTang. A true collaboration between @WeillCornell & @sloan_kettering and special thanks to Yu Chen ! biorxiv.org/content/10.1101/…
7
20
65
Irfan Asangani retweeted
Congratulations to Dr. Irfan Asangani, PhD @AsanganiLab of University of Pennsylvania @PennEpiInst a recipient of our 2020-2022 Conquer Cancer Now Award #grant for their #CancerResearch project in #ProstateCancer
#Immunology concernfoundation.org/donate…
Or TEXT CONCERN to 77948
4
1
13
Repurposing Cancer Drugs for COVID-19 cancerdiscovery.aacrjournals…
3
Excited to share our new story on COVID-19. Our results have implications for understanding male bias in COVID-19 severity and mortality, and provide a strong rationale for androgen deprivation or anti-androgen therapy in men with SARS-CoV-2 infection.
biorxiv.org/content/10.1101/…
8
13
43
Irfan Asangani retweeted
Excited to share our story "Cell Cycle Checkpoints Cooperate to Suppress DNA and RNA-Associated Molecular Pattern Recognition and Anti-Tumor Immune Responses". Really a team effort to make it happen @RogerRogergr @brokendna Big thanks to our collaborators @andyjminn @AsanganiLab
Congratulations to Jie and Shane on their new paper, "Cell Cycle Checkpoints Cooperate to Suppress DNA and RNA-Associated Molecular Pattern Recognition and Anti-Tumor Immune Responses" cell.com/cell-reports/pdfExt…
3
2
15
Irfan Asangani retweeted
Our paper is out, finally. Congratulations to first authors, @ritika0107 & @ManzarNishat, coauthors, collaborators @NallasivamPala4 @mishabeltran @AminaZoubeidi @FKhaniPath. Thanks to @India_Alliance for funding. Thanks @DBTIndia @serbonline @IITKanpur
nature.com/articles/s41467-0…
41
36
259
Irfan Asangani retweeted
Epigenetic Regulation of Chromatin in Prostate Cancer. 𝘼𝙙𝙫 𝙀𝙭𝙥 𝙈𝙚𝙙 𝘽𝙞𝙤𝙡.
ncbi.nlm.nih.gov/pubmed/3190…
#ProstateCancer @AsanganiLab
bit.ly/2R4E5IL
1
1
Irfan Asangani retweeted
Our chapter on PCa #metabolism. Part of a new book-"Prostate Cancer--Cellular & Genetic Mechanisms of Disease Development and Progression" edited by @scottdehm +Don Tindall.
Other great contributions from @AminaZoubeidi @drleighellis @DrSpratticus @quimmateo @AsanganiLab +more
Prostate Cancer Energetics and Biosynthesis. 𝘼𝙙𝙫 𝙀𝙭𝙥 𝙈𝙚𝙙 𝘽𝙞𝙤𝙡.
ncbi.nlm.nih.gov/pubmed/3190…
@DanielFrigo
#ProstateCancer
bit.ly/37KStN0
7
27
Irfan Asangani retweeted
excited to see our paper @nature today! We showed how gain-of-function mutations in chromatin reader ENL work to drive Wilms tumor. Fantastic collaborations with many great colleagues in Allis Wen @TjianDarzacq Roeder @Muirlab @KentsisResearch Li labs!
nature.com/articles/s41586-0…
7
49
207
Irfan Asangani retweeted
Excellent News & Views on our paper out in Nature! We find alcohol metabolites attach to brain chromatin and affect learning! @berger_lab @PennEpiInst @PennMedNews @PennIDOM @SinaiBrain @MountSinaiPsych check it out: nature.com/articles/s42255-0…
1
16
45
Irfan Asangani retweeted
Interested in studying cancer epigenetics? Our new lab at UPenn has openings for postdoctoral scientists, students, and research assistants. check out lilingwanlab.com/open-positi… for more information and how to apply.
1
35
57
Irfan Asangani retweeted
Congrats to @WellenLab, @AsanganiLab, and the Marmorstein lab for receiving an AFCRI Discovery Pilot Grant for a collaborative project entitled “Probing the metabolism-epigenetics link as a therapeutic target in prostate cancer” 🎉🎊🙌🏽
5
18